GSK692342
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK692342, covering 2018-08-13 to 2018-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults [Phase 2]